和誉医药上半年利润大增59%,潜在“十亿美元分子”还在输出

医药研究社
Aug 06, 2025

和誉医药的“弹药库”越来越充实。来源|医药研究社创新药井喷的关口,市场越来越期待更多“十亿美元分子”出现,即便是一款潜在的、尚未商业化的“十亿美元分子”,似乎也能让药企快速开启上行通道。对这一点,和誉医药应该深有体会。8月5日,和誉医药的半年报新鲜出炉:今年上半年,公司实现营收6.12亿元,同比增长23%;利润3.28亿元,同比增长59%;经调整净利润3.36亿元,同比大增56%;现金储备(包括...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10